NCT07494318 Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.
| NCT ID | NCT07494318 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Methodist Health System |
| Condition | Gastro-Intestinal Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 260 participants |
| Start Date | 2018-08-02 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 260 participants in total. It began in 2018-08-02 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this anonymous survey is to identify who teaches GI procedures to general surgical residents during residency training and understand the need as well as desire for an Advanced Surgical GI fellowship amongst senior surgical residents. We also hope to identify the self-reported level of comfort of senior general surgery residents in completing both common and complex GI procedures.
Eligibility Criteria
Inclusion Criteria: All fourth and fifth year general surgery residents in accredited Accreditation Council for Graduate Medical Education(ACGME) general surgery residency programs in the United States. Exclusion Criteria: All junior general surgical residents (third year residents through interns) will be excluded from the study.
Contact & Investigator
Rohan Jeyarajah, MD
PRINCIPAL INVESTIGATOR
Methodist Health System
Frequently Asked Questions
Who can join the NCT07494318 clinical trial?
This trial is open to participants of all sexes, studying Gastro-Intestinal Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07494318 currently recruiting?
Yes, NCT07494318 is actively recruiting participants. Contact the research team at ClinicalResearch@mhd.com for enrollment information.
Where is the NCT07494318 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT07494318 clinical trial?
NCT07494318 is sponsored by Methodist Health System. The principal investigator is Rohan Jeyarajah, MD at Methodist Health System. The trial plans to enroll 260 participants.